Biofrontera Inc.

BFRI

Healthcare|Medical - Pharmaceuticals|US

$0.83

+0.02 (+2.50%)

Tangible Book / Share

$0.26

Cash / Share

$0.36

Next Earnings Report

Nov 11, 2026

EPS est. -$0.22 · Revenue est. $8.3M

Financing Filings (last 12 months)

Shelf registrations / offering prospectuses — latest Dec 5, 2025 (S-1). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Awaiting Results (2)

Trials past primary completion date but still active — data readout may be imminent.

Oct 2026

Cryotherapy in Combination With Red Light PDT for Actinic Keratosis of Full Face

NCT06745999

Mar 2024

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

NCT03573401

Recent Press Releases

Biofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026

Nov 6, 2026 · GlobeNewsWire

Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full Body

Oct 8, 2026 · GlobeNewsWire

Biofrontera Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma

Sep 14, 2026 · GlobeNewsWire

Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth

Aug 13, 2026 · GlobeNewsWire

SEC Filings (74)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

Filed	Form	What it is	Links
Oct 30, 2026	25-NSE		Document Index
Sep 14, 2026	8-K	Material event	Document Index
Aug 13, 2026	10-Q	Quarterly report	Document Index
Aug 13, 2026	8-K	Material event	Document Index
Aug 12, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Jul 22, 2026	S-8	Employee stock plan	Document Index
Jul 22, 2026	10-K/A	Annual report	Document Index
Jun 17, 2026	8-K	Material event	Document Index
May 14, 2026	10-Q	Quarterly report	Document Index
May 14, 2026	8-K	Material event	Document Index
Apr 30, 2026	DEF 14A	Proxy / shareholder vote	Document Index
Mar 19, 2026	10-K	Annual report	Document Index
Mar 19, 2026	8-K	Material event	Document Index
Mar 9, 2026	8-K	Material event	Document Index
Feb 26, 2026	8-K	Material event	Document Index
Feb 11, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Feb 9, 2026	8-K	Material event	Document Index
Jan 28, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Jan 13, 2026	8-K	Material event	Document Index
Jan 7, 2026	8-K	Material event	Document Index
Dec 19, 2025	EFFECT		Document Index
Dec 5, 2025	S-1	IPO / offering registration	Document Index
Nov 13, 2025	8-K	Material event	Document Index
Nov 12, 2025	10-Q	Quarterly report	Document Index
Nov 12, 2025	SC 13G/A	Passive 5%+ stake	Document Index
Nov 10, 2025	8-K	Material event	Document Index
Nov 7, 2025	8-K	Material event	Document Index
Oct 24, 2025	8-K	Material event	Document Index
Oct 23, 2025	8-K	Material event	Document Index
Sep 19, 2025	8-K	Material event	Document Index
Sep 19, 2025	SC 13D/A	Activist / 5%+ stake	Document Index
Aug 19, 2025	EFFECT		Document Index
Aug 13, 2025	S-1/A	IPO / offering registration	Document Index
Aug 13, 2025	8-K	Material event	Document Index
Aug 13, 2025	10-Q	Quarterly report	Document Index
Aug 11, 2025	8-K	Material event	Document Index
Aug 11, 2025	SC 13G/A	Passive 5%+ stake	Document Index
Aug 5, 2025	DEF 14A	Proxy / shareholder vote	Document Index
Jul 25, 2025	PRE 14A	Proxy / shareholder vote	Document Index
Jul 25, 2025	SC 13D/A	Activist / 5%+ stake	Document Index